NEI Research News

NEI-funded investigators at Washington University in St. Louis discovered a potential new treatment approach to diabetic retinopathy, one of the most common causes of vision loss in the U.S.

In primates, activity in the visual cortex—a part of the brain that processes signals from the eyes—is largely unaffected by the body’s own movements, according to a new study from scientists at the National Eye Institute (NEI).

The K99/R00 provides a runway for postdocs seeking to transition from mentored positions to tenure track positions at academic institutions in the U.S.

A summary of the April 11, 2023, workshop, "NEI-NIMHD Vision Health Equity Workshop," is available on the NEI website.

Ribosomal protein genes that are found at low levels in adult nerve cells may be very important to axon regeneration.

Members of the National Eye Institute's Audacious Goals Initiative (AGI) published an outline of milestones to reach before commencing clinical trials of regenerative therapies for retinal disease.

Using a technique they developed for studying eye fluid, Stanford Medicine researchers and their collaborators have found a way to measure ocular aging, opening avenues for treatment of numerous eye diseases.

The National Eye Institute (NEI) is pleased to announce the election of Michael F. Chiang, M.D. to the National Academy of Medicine.

Ruchi Sharma, Ph.D., a staff scientist in the NEI Ocular and Stem Cell Translational Section, received an award from the Knights Templar Eye Foundation (KTEF), a charity sponsored by the Grand Encampment of Knights Templar.

A research team has discovered that a non-invasive eye exam may be a possible tool for screening Black Americans and other people from underdiagnosed and high-risk populations for cerebral small vessel disease, a major contributor to cognitive impairment.